Otsuka Pharmaceutical acquires common shares of MethylGene inc.
The common shares were acquired for investment purposes and not with a view to effecting control of MethylGene. Otsuka Holdings and its affiliates will evaluate their investment in MethylGene from time to time and may, based on such evaluation of market conditions and other circumstances, increase or decrease shareholdings in the company as circumstances require.
About Otsuka Pharmaceutical Co., Ltd.
Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: 'Otsuka-people creating new products for better health worldwide.' Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to the high ethical standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural environment.
Otsuka Pharmaceutical Co., Ltd. is a wholly owned subsidiary of Otsuka Holdings Co., Ltd., the holding company for the Otsuka Group. The Otsuka Group comprises 153 companies and employs approximately 36,000 people in 23 countries and regions worldwide. Otsuka and its consolidated subsidiaries earned (Yen)955.9 billion (approx. US $9.7 billion*) in annual revenues in fiscal 2008.
* Exchange rate as of